KCT0002545招募中未知
Prospective, single-center, randomized, controlled clinical validity and reliability for evaluation of high-frequency stimulation targeted at patients with shoulder pain (HIPER-500), studies also frequently
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 38
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 65(Year)（—）
- 性别
- All
入选标准
- •1) Age 19-65, Man and woman
- •2) Shoulder Pain Patients
- •3) Normal cognitive function
- •4) The patients has subscribed the informed consent
排除标准
- •1) Non-age-matched
- •2) suspected neurological disease
- •3) sense of degradation
- •4) Shoulder surgery less than 6 months
研究者
相似试验
招募中
不适用
Prospective, randomized controlled, single center study evaluating additional respiration therapy with a PEP trainer to prevent pneumonia in patients with higher neutropenic risk under chemotherapeutic treatment of an acute myeloic leukemiaC92J18Myeloid leukaemiaPneumonia, organism unspecifiedDRKS00019842Vivantes Klinikum Neukölln - Hämatologie, Onkologie und Palliativmedizin100
尚未招募
不适用
A prospective, single-center, randomized, controlled, evaluator-blinded(independent evaluator), feasibility clinical trial to evaluate efficacy and safety of Pulsed High-Intensity Focused Ultrasound therapy ‘IMD10’ with neoadjuvant in pancreatic cancerKCT0008066IMGT30
已完成
不适用
Prospective, single-center, randomized, single-blind sham-controlled study of the urinary dysfunction treatment device O-NES in patients with overactive bladder who are unresponsive to or unsuitable for conservative therapy (pilot study)Overactive bladderJPRN-UMIN000037890Otsuka Techno Corporation47
尚未招募
4 期
A prospective, multicenter, randomized, controlled study to evaluate the clinical outcome of Zhenyuan capsule in the treatment of heart failure after myocardial infarctioHeart failure after myocardial infarctionITMCTR2200005706Zhongshan Hospital affiliated to Fudan University
进行中（未招募）
不适用
A multicenter, randomized, prospective, controlled study to evaluate the efficacy and the tolerability of a switch to a two different-dosed, nevirapine-based HAARTs in HIV-1 infected patients with undetectable plasma viremia. - SNODOEUCTR2006-002582-39-ITFONDAZIONE NADIR ONLUS200